Trials / Completed
CompletedNCT02385396
Myo-inositol Therapy on the Dynamics of Embryo Development in Patients Suffering From PCOS Undergoing ICSI Treatment
Evaluation Concerning the Influence of Myo-inositol Therapy on the Dynamics of Embryo Development in Patients Suffering From PCOS Undergoing ICSI Treatment
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 217 (actual)
- Sponsor
- Medical University of Lublin · Academic / Other
- Sex
- Female
- Age
- 27 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to analyse the activity of myo-inositol on pregnancy rate, embryo development dynamics and oestradiol and progesterone concentration in blood serum and Superoxide Dismutase (SOD) and catalase concentration in follicular fluid of patients with Polycystic Ovary Syndrome (PCOS) undergoing Intracytoplasmic Sperm Injection (ICSI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Inofolic: myo-inositol and folic acid | 4000 mg of myo-inositol and 0,4 mg of folic acid for 3 months preceding the ICSI procedure |
Timeline
- Primary completion
- 2014-10-01
- First posted
- 2015-03-11
- Last updated
- 2015-03-12
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT02385396. Inclusion in this directory is not an endorsement.